Rhythm Pharmaceuticals Inc. Tech Stack

Commercial-stage biotech focused on rare neuroendocrine and genetic obesity diseases

Biotechnology Research Boston, MA 201–500 employees Founded 2008 Public Company

Rhythm Pharmaceuticals is a public biotech company developing medicines for rare genetic diseases centered on the MC4R pathway, with commercial operations in North America and Europe. The hiring velocity is accelerating across sales, healthcare, and marketing roles—14 senior hires and 13 managers in the active pipeline—while the company is simultaneously managing complex reimbursement landscapes and patient identification challenges that signal scaling pressures typical of rare-disease commercialization.

Tech Stack 21 technologies

Core StackADP Smartsheet Salesforce Snowflake Power BI Python AWS Azure AD WordPress ADP Workforce Now CRM E*TRADE Concur GCP WP Engine Azure IAM VPC DNS SSL/TLS Ironclad

What Rhythm Pharmaceuticals Inc. Is Building

◆Challenges

Complex markets with diverse customer segments
Access and reimbursement challenges
Treatment access barriers
Efficiency and commercialization process improvement
Optimizing patient support programs
Unmet needs of rare genetic obesity patients
Identifying patients with rare genetic obesity
Process improvements within regulatory operations
Enhancing operational effectiveness
Untreatable rare neuroendocrine diseases

▲Active Projects

Disease and branded education to hcps
Patient enrollment education
Internal genetic testing programs
Injection education training program
Product theater leadership
Integrated strategic and tactical plan
Pre-launch and launch of new developments
Scientific communication plans
O2c process improvement initiative
Sales and inventory reconciliation

Hiring Activity

Accelerating30 roles · 25 in 30d

Department

Sales

Healthcare

Marketing

Finance

Research

Communications

Data

Executive

Seniority

Senior

Manager

Director

Notable leadership hires: Chief of Staff, Head of Strategic Sourcing

Company intelligence

Find more companies like Rhythm Pharmaceuticals Inc. by tech stack, pain points and active projects

Get started free

About Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals develops medicines for rare neuroendocrine diseases and genetic obesity, with a commercial-stage lead asset in market and a clinical pipeline targeting MC4R pathway disorders. The company operates globally with established commercial infrastructure in North America, Europe, and other regions, supported by a 201–500-person workforce headquartered in Boston. Core operational focus spans disease and patient education, clinical trial enrollment, internal genetic testing programs, and regulatory process improvement. Key challenges center on navigating complex reimbursement pathways, identifying rare-disease patients, and optimizing support programs for healthcare providers and families.

HeadquartersBoston, MA

Company Size201–500 employees

Founded2008

Hiring MarketsUnited States, United Kingdom, Germany, Austria, Switzerland, Netherlands, Canada

Frequently Asked Questions

What tech stack does Rhythm Pharmaceuticals use?

ADP Workforce Now and Salesforce for operations, Snowflake and Power BI for analytics, Python for development, AWS and Azure for cloud infrastructure, and specialized contract/IP tools like Ironclad.

Where does Rhythm Pharmaceuticals hire internationally?

United States, United Kingdom, Germany, Austria, Switzerland, Netherlands, and Canada across current open roles.

How this profile is built

Rhythm Pharmaceuticals Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.